|
| Clinical observation on Garidisan in 60 patients with ulcerative colitis |
| Hits 1860 Download times 1457 Received:October 14, 2011 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2012.01.06 |
| Key Words
ulcerative colitis;Mongolian medicine therapy;Garidisan |
| Author Name | Affiliation | | CUI Jian | China Minority Traditional Medical Center, Minzu University of China, Beijing 100081, China | | PANG Zong-ran | China Minority Traditional Medical Center, Minzu University of China, Beijing 100081, China | | DE Li-ge-ma | Inner Mongolia Medical College, Huhehaote 010059, China | | LU Bi-nan | China Minority Traditional Medical Center, Minzu University of China, Beijing 100081, China | | LIU Wei-zhi | China Minority Traditional Medical Center, Minzu University of China, Beijing 100081, China |
|
| Abstract
|
| [Objective] To observe the clinical effect of Garidisan in treating ulcerative colitis.[Methods] One hundred and twenty patients were randomly divided into two groups.Sixty patients in treatment group were treated with Garidisan,while 60 patients in control group received oral Salazosulfadimidine(SASP).[Results] The effective rate of treatment group was 93.3% and control group was 73.3%.There were significant differences between two groups(P<0.05).After treatment of Garidisan,the main symptoms of ulcerative colitis,such as diarrhea,abdominal pain,mucous stool with pus and blood and tenesmus,were significantly improved.[Conclusion] Garidisan has a significant clinical effect in treating ulcerative colitis and its signs without any adverse reaction. |
|
|
|
|
|
|
|
